Metformin exhibits TWIST dependent anti-tumor properties by inhibiting N-cadherin and NF-κB signaling without affecting E-cadherin in wild-type N-cadherin expressing tumor cells including prostate, bladder, and kidney [170]. Here, CDH2 is linked to neoplasm.